Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-24,764
Closed -$1.39M 248
2016
Q4
$1.39M Sell
24,764
-21,201
-46% -$1.24M 0.56% 66
2016
Q3
$2.74M Buy
+45,965
New +$2.69M 0.91% 37
2015
Q4
Sell
-1,153
Closed -$54K 259
2015
Q3
$54K Sell
1,153
-42,171
-97% -$2.24M 0.01% 232
2015
Q2
$2.35M Sell
43,324
-7,714
-15% -$433K 0.43% 79
2015
Q1
$2.8M Buy
+51,038
New +$2.89M 0.5% 68
2014
Q4
Sell
-10,564
Closed -$598K 528
2014
Q3
$598K Buy
+10,564
New +$593K 0.04% 387
2013
Q3
Sell
-79,114
Closed -$3.51M 647
2013
Q2
$3.51M Buy
+79,114
New +$3.53M 0.05% 382

Other funds holding MRK

Turner Investments's MRK Position: Q1 2017 in Review

Turner Investments sold out of Merck (MRK) in Q1 2017, closing a stake of 24,764 shares — an estimated $1.39M sold.

Turner Investments first reported a position in MRK in Q2 2013 and held it in 7 quarters. The position peaked at $3.51M in Q2 2013. 1,941 funds tracked by Wall St. Rank hold MRK as of Q1 2017.

  • Turner Investments reported no remaining Merck position as of Q1 2017 after selling out during the quarter.
  • Turner Investments sold 24,764 Merck shares in Q1 2017, an estimated $1.39M.
  • Turner Investments first reported a position in Merck in Q2 2013 and held it in 7 quarters.
  • Turner Investments's Merck position peaked at $3.51M in Q2 2013.
  • 1,941 funds tracked by Wall St. Rank held Merck as of Q1 2017.

Based on Turner Investments's 13F filing for Q1 2017, filed 11 May 2017.